Skip to main content
. 2014 Oct 13;20(12):1029–1035. doi: 10.1111/cns.12329

Table 2.

Baseline demographics, risk factors, and clinical measures by HRQOL category

All (N = 5104) Poor HRQOLa (N = 294) Good HRQOL (N = 4810) P
Age (year), mean (SD) 62.6 ± 10.7 65.2 ± 11.0 62.4 ± 10.7 <0.001
Female sex, n (%) 1728 (33.9) 117 (39.8) 1611 (33.5) 0.03
Han ethnic, n (%) 5034 (98.6) 290 (98.6) 4744 (98.6) 1.00
Body mass index, mean (SD) 24.7 ± 3.0 24.8 ± 3.1 24.7 ± 3.0 0.18
Vascular risk factors, n (%)
Ischemic stroke 1018 (20.0) 56 (19.0) 962 (20.0) 0.69
TIA 172 (3.4) 10 (3.4) 162 (3.4) 0.98
Myocardial infarction 92 (1.8) 6 (2.0) 86 (1.8) 0.75
Congestive heart failure 77 (1.5) 7 (2.4) 70 (1.5) 0.31
Known atrial fibrillation or flutter 173 (3.4) 10 (3.4) 163 (3.4) 0.99
Hypertension 3358 (65.8) 219 (74.5) 3139 (65.3) 0.001
Diabetes mellitus 1083 (21.2) 82 (27.9) 1001 (20.8) 0.004
Dyslipidemia 560 (11.0) 34 (11.6) 526 (10.9) 0.74
Current or previous smoking 2191 (42.9) 106 (36.1) 2085 (43.3) 0.01
Alcohol consumption 1582 (31.0) 85 (28.9) 1497 (31.1) 0.43
Index event, n (%)
Minor stroke 3677 (72.0) 249 (84.7) 3428 (71.3) <0.001
TIA 1427 (28.0) 45 (15.3) 1382 (28.7)
Premorbid mRS, n (%)
0 4212 (82.5) 249 (84.7) 3963 (82.4) 0.30
1 757 (14.8) 39 (13.3) 718 (14.9)
2 135 (2.6) 6 (2.0) 129 (2.7)
NIHSS at baseline, median (IQR) 2 (0–2) 2 (1–3) 1 (0–2) <0.001
In‐hospital treatment, n (%)
Antihypertensive 1450 (28.4) 17 (5.8) 1433 (29.8) <0.001
Hypoglycemic 520 (10.2) 6 (2.0) 514 (10.7) <0.001
Lipid‐lowering 1824 (35.7) 22 (7.5) 1802 (37.5) <0.001
Dual antiplatelet 2550 (50.0) 129 (43.9) 2421 (50.3) 0.03

HRQOL, Health‐related quality of life; SD, standard deviation; IQR, interquartile range; mRS, modified Rankin score; NIHSS, National Institutes of Health stroke scale; TIA, transient ischemic attack. aPoor HRQOL defined as EQ‐5D index score of 0.5 or less using the Chinese preference weights. Comparison by chi‐square test for categorical and t‐test or Mann–Whitney U‐test for continuous variables.